Clinical Leader - Helping clinical research professionals connect and collaborate

Working hard for success-GettyImages-2201479298

Pharma Procurement Can Make Or Break Startups: Let's Help Mature Our Future Partners To Secure Innovation

To secure long-term innovation, Ascendis Pharma's Ivanna Rosendal suggests pharma companies should help startup companies through their growing pains.

GUEST COLUMNISTS

Want To Optimize Clinical Project Team Performance? Try This Formal 'Lessons Learned' Process
Learn how a formal "lessons learned" process can help teams work collaboratively with open, honest, and timely communication to reach thoughtful decisions that lead to on-time, on-budget, and inspection-ready trials.
4 Factors Changing The Way CRAs Monitor Trials
The way CRAs monitor is about to change. Regeneron's Patrick Floody discusses these four factors that will influence it.
How Can AI Change Computerized System Validation?
Learn how AI technologies are changing the computer system validation (CSV) landscape and what you need to understand about this transformation.
Too Little Info, Too Much Time Wasted: Feasibility Challenges For Sites
Incomplete protocols, lengthy sponsor decision timelines, and uncompensated work plague clinical research sites. Learn why these issues exist and how to address them alongside experts from SCRS and Tufts CSDD.
Will New AI Health Assistants Suggest Clinical Trials To Inquiring Patients?
New AI health assistants are now doing even more to help patients make sense of symptoms, diagnoses, and treatment options. What does that mean for the discoverability of clinical trials?
What CROs Do Right Isn't Always Obvious To Research Sites
CROs are doing many things right. But it's when that right thing is understood — not just executed — that the impact becomes far greater than compliance alone.
How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials
VP of Clinical Development, HIV, Moupali Das shares how the sponsor approaches diverse participant recruitment and enrollment, highlighting the importance of early demographic research and careful, intentional PI selection.
3 Clinical Research Attorneys Talk 2026 Trends
Three life sciences legal experts share what they see happening in the year ahead — and what should remain firmly in the past.

CLINICAL TRIAL WHITE PAPERS

Digital Endpoint Resource Guide: Parkinson's Disease
Explore how sensor-based digital health technologies can revolutionize the treatment and management of movement disorders by providing more accurate, patient-centered outcomes.

Antibody-Drug Conjugates: 'Magic Bullets' Become Reality
2/19/2025

Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including antibody-drug conjugates (ADCs). Learn more about ADCs’ makeup, mechanisms, and the development landscape.
Site Perspectives On BYOD ePRO Use
6/17/2024

This study examines participant convenience and compliance, aiming to understand and address the challenges faced by site personnel in global trials.
Patient Diversity: Identifying Challenges, Opportunities, And Best Practices
4/10/2024

By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
Hepatitis B - Global Clinical Trial Landscape
3/6/2025

As Hepatitis B virus (HBV) clinical trials advance, refining therapeutic endpoints and integrating novel treatment strategies are essential to transforming Hepatitis B management.
Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data Collection
7/25/2024

Explore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.

More Clinical Trial White Papers

CLINICAL TRIAL APP NOTES & CASE STUDIES

Top 20 Pharma Accelerates Training And Enrollment Across 650 Site Staff
5/14/2024

With Longboat, this pharma company trained all staff across trial sites, ensuring treatment for all 20,000 patients with real-time training reports.
Digital Outcome Measures Approved As Primary Endpoint In Cardiopulmonary Study
4/15/2025

Discover how a clinical development program was saved using objective, continuous digital outcome measures.
Streamlining Phase 1 Trials With The Mobile Vision Pod
1/29/2025

A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.
Enhancing ER Patient Recruitment
6/26/2024

Scout's custom information delivery mechanism for clear, accessible patient education facilitated trial enrollment in a high-pressure emergency room setting.
Analytics–Powered Approach To Patient Recruitment Strategy
7/15/2025

In a Phase 3 psychiatry trial, a pharmaceutical company partnered with Signant to revolutionize patient recruitment through data-driven site selection using PureSignal Analytics.
Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis
6/10/2025

Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.

More Clinical Trial App Notes & Case Studies

NEWSLETTER ARCHIVE

More Newsletters

RECRUITMENT AND DIVERSITY

This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.

Building Patient Trust In Research Through Connection Driven-Transparency

The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.
Patient Trust In Pharma Is Low; Here's How To Rebuild It

CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.
The U.S. Trial Advantage Is Eroding

Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.

FOCUS ON PATIENTS

Building Patient Trust In Research Through Connection Driven-Transparency

The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.
Patient Trust In Pharma Is Low; Here's How To Rebuild It

CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.
How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials

VP of Clinical Development, HIV, Moupali Das shares how the sponsor approaches diverse participant recruitment and enrollment, highlighting the importance of early demographic research and careful, intentional PI selection.